Announcing a new article publication for BIO Integration journal. Bladder cancer (BLCA) is one of the most common malignancies and the second most frequent urogenital tract tumor. Cell and gene ...

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Following this standard treatment regimen, the rodents develop recurrent tumors, establishing what is referred to as an ...

As the workforce has become more mobile, businesses are increasingly dependent on cell phones to stay connected to employees while they’re working from home, commuting to the office or traveling.

If adults have nucleated red blood cells (NRBCs) in their blood, it’s usually a sign of a life threatening condition. The optimal NRBC count is 0. Even very low NRBC counts could cause a doctor ...

CAR T-cell therapy can be expensive, but there are a few ways you can manage costs. How Much Is CAR T-Cell Therapy? Experts estimate that CAR T-cell therapy can cost between $500,000 and $1,000,000.

High expression genes of different cell types; the relative expression of marker genes in cells; statistics of the number of different genes in different cells; qPCR primers used in the experiment; ...

The basic technology behind Ambient Photonics’s solar cells is so simple that it’s routinely assembled as a high school science experiment. In labs across the US, students sandwich ...

A failed Soviet Venus probe is expected to fall to Earth today, but when and where? Here's what we know CBS explains decision to cancel The Equalizer and FBI spin-offs: ‘It’s not easy’ Tesla ...

EchoBack CAR T-cells are smart immune warriors that respond to ultrasound to fight cancer longer and more safely than ever before. They promise a big leap in treating solid tumors. Credit: ...

Related: New Type of Stem Cell Transplant Shows Promise in Type 1 Diabetes In June 2023, the FDA approved CellTrans’ Lantidra (donislecel) as the first cellular therapy for type 1 diabetes. But ...

Researchers at Memorial Sloan Kettering Cancer Center (MSK) have announced progress on that front — they have developed a new therapy that uses stem cells to treat advanced Parkinson’s.